The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
IDeate-PanTumor02: A phase 1b/2 study to evaluate the efficacy and safety of ifinatamab deruxtecan (I-DXd) in patients (pts) with recurrent or metastatic solid tumors.
 
Takahiro Kogawa
Consulting or Advisory Role - Astellas Pharma; Daiichi Sankyo
Speakers' Bureau - Astellas Pharma; AstraZeneca; Chugai Pharma; Daiichi Sakyo; Eisai; Gilead Sciences; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Lilly (Inst)
 
Seiichiro Mitani
Honoraria - MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Chugai Pharma
 
David Berz
Employment - Valkyrie Clinical Trials
Leadership - Jazz Pharmaceuticals; Sun Pharma
Honoraria - EMD Serono; Jazz Pharmaceuticals; Sun Pharma
Research Funding - Ascendis Pharma; BeiGene; BioNTech; Black Diamond Therapeutics; Boehringer Ingelheim; Bristol Myers Squibb; eFFECTOR Therapeutics; Faeth Therapeutics; G1 Therapeutics; Genprex; Hongyun Biotech; Incyte; InhibRx; Mirati Therapeutics; Seagen; Summit Therapeutics; WhiteOak; Xencor
Travel, Accommodations, Expenses - EMD Serono; Jazz Pharmaceuticals
 
Diego Reis
Employment - Daiichi Sankyo Europe GmbH
Stock and Other Ownership Interests - Daiichi Sankyo Europe GmbH
Travel, Accommodations, Expenses - Daiichi Sankyo Europe GmbH
 
Cindy Li
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
Research Funding - Daiichi Sankyo
 
Tatiane Ishida
Employment - Daiichi Sankyo
 
Keyi Wang
Employment - Daiichi Sankyo
 
Kristi Schmidt
Employment - Merck; Seagen
Stock and Other Ownership Interests - Merck; Seagen
Travel, Accommodations, Expenses - Merck; Seagen
 
Shigehiro Koganemaru
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Daiichi-Sankyo (Inst); Incyte (Inst); MSD (Inst)